Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | |||
Founding Date | Founding Date 2003 | Founding Date 2013 | Founding Date 2011 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Bundoora, AU HQ München, DE Hummelstown, US | Locations København, DK HQ | Locations Montpellier, FR HQ Grabels, FR |
Employees | Employees 20 | Employees 7 | Employees 614% decrease |
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company
SurgiMab is a company that develops of intraoperative detection of tumors.
View company